PITTSBURGH -- (BUSINESS WIRE) -- Dr. Mae C. Jemison, longtime national spokesperson for Bayer Corporation’s award-winning Making Science Make Sense® program, will be the featured speaker at “STEM Saves Lives,” hosted by U.S. News & World Report in partnership with the Pharmaceutical Research and Manufacturers of America (PhRMA).
The conference will be held at the National Press Club in Washington, D.C. on Wednesday, January 22, 2014. The event will feature a series of panels focusing on how the biopharmaceutical industry is investing in STEM education and how these best practice case studies can serve as models for other STEM-related industries.
Dr. Jemison, chemical engineer, physician, educator and former U.S. astronaut, will highlight key components of Making Science Make Sense®, Bayer’s best practice STEM education initiative. Additionally, Dr. Jemison will offer recommendations for how other biopharmaceutical companies can get involved in supporting programs that have a track record of helping students succeed in STEM subjects. She will also address her personal STEM journey and the importance of bringing more women, African-Americans, Hispanics and American Indians into the nation’s STEM fields.
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research and biotechnology companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. Since 2000, PhRMA member companies have invested approximately $550 billion in the search for new treatments and cures, including an estimated $48.5 billion in 2012 alone. - See more at: http://www.phrma.org.
About Bayer Corporation and Making Science Make Sense®
Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. As an inventor company, it sets trends in research-intensive areas. Bayer’s products and services are designed to benefit people and improve the quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and acts as a socially and ethically responsible corporate citizen. In fiscal 2012, the Group employed 110,500 people and had sales of €39.8 billion. In North America, Bayer had 2012 net sales of €9,576 million ($12,257 million) and employed 15,300 at year-end. For more information, go to www.bayerus.com.
Formalized in 1995, Making Science Make Sense is Bayer’s national award-winning initiative to advance science literacy through hands-on, inquiry-based science learning, employee volunteerism and public education.
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.